Randomized Controlled, Open-Label, Phase IIb/III Study of Lurbinectedin in Combination with Doxorubicin Versus Doxorubicin Alone As First-Line Treatment in Patients with Metastatic LeiomyosarcomaGregory Michael Cote,Sant P. Chawla,George Demetri,Bernd Kasper,Robin Lewis Jones,Javier Martin Broto, Joseph Wooley,Mia C. Weiss,Salvatore Tafuto,Giuseppe Badalamenti,Irene Carrasco-Garcia,Paloma Peinado,Jean-Yves Blay, Gaston Boggio,Cristian Marcelo Fernandez,Antonio Nieto,Carmen Maria Kahatt,Ali Hassan Zeaiter,Axel Le CesneJOURNAL OF CLINICAL ONCOLOGY（2024）引用 0|浏览10AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
